Skip to main content

A Retrospective Cohort Study Comparing the Impact of Two Oscillating Positive Expiratory Pressure (OPEP) Devices in Patients with Chronic Obstructive Pulmonary Disease (COPD) or Chronic Bronchitis on Hospital Readmissions at 30 Days and 12 Months

Conclusions
  • Results from this study demonstrate a reduction in the proportion of patients requiring COPD/chronic bronchitis related readmission within 30 days and 12 months of the Aerobika® OPEP device therapy initiation compared to an alternative OPEP device.
     
  • This further supports the use of the Aerobika® OPEP device as an add-on to usual care to manage COPD/chronic bronchitis patients post-exacerbation and highlights that not all OPEP devices are the same in terms of 30-day and 12-month readmissions

 

 

aerobika_main-image

Request a Demo Kit

We can provide a complimentary demonstration kit for verified healthcare professionals.

Recommended Solutions

Aerobika OPEP Device from the front

AEROBIKA* OPEP Device

For drug-free therapy or can be used with a nebulizer

A drug-free and easy to use device that can help open weak airways and to loosen mucus, so it can be coughed out.

Aerochamber Flow

AEROCHAMBER PLUS* FLOW-VU* Chamber

For use with your metered dose inhaler

This AEROCHAMBER PLUS* spacer includes the FLOW-VU* indicator and FLOWSIGNAL* whistle and comes in several sizes.

AeroChamber 2Go Chamber with inhaler

AEROCHAMBER2GO* Chamber

For use with your metered dose inhaler while on the go
Ideal for adolescents and adults while on the go, the 2-in-1 chamber is also an inhaler storage case.